An internally validated simple scoring model using clinical factors successfully predicts the likelihood of detecting ...

In episode four of Chat!DNA, an interview series by BGI Genomics, we feature Lin Cong, whose research on colorectal cancer, ...

They used the CRC Simulated Population model for Incidence and Natural history to create a simulated cohort of 10 million individuals aged 50 years in 2025, representing a mostly Hispanic/Latino ...

Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.

CRC is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. And, based on the above valuation metrics, we feel that CRC is likely the superior value ...

This study explores the potential of oncomicrobial vaccines in mitigating tumor progression by targeting specific ...

Excellon Resources Inc. (TSX: EXN) (FSE: E4X2) ("Excellon" or the "Company") is pleased to announce a definitive agreement (the "Adar and Premier Agreement") has been executed between Adar Mining Corp ...

Impact of expression of metabolic genes on patient (pts) outcomes in metastatic colorectal cancer (mCRC): Data from CALGB/SWOG 80405 (Alliance). This is an ASCO Meeting Abstract from the 2025 ASCO ...